Intravenous Zotatifin in Adults With Mild or Moderate COVID-19

Clinical trial NCT04632381 · COMPLETED

Trial details

NCT number: NCT04632381
Sponsor: Effector Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Corona Virus Infection

Start date: 2021-07-01
Primary completion: 2023-01-12
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.